Organon & Co (OGN)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 864,000 | 1,301,000 | 1,000,000 | 1,047,000 | 1,023,000 | 585,000 | 754,000 | 746,000 | 917,000 | 1,011,000 | 1,107,000 | 1,300,000 | 1,351,000 | 1,517,000 | 1,741,000 | 1,856,000 | 2,160,000 |
| Total stockholders’ equity | US$ in thousands | 472,000 | 493,000 | 144,000 | 48,000 | -70,000 | -589,000 | -555,000 | -737,000 | -892,000 | -1,066,000 | -1,137,000 | -1,250,000 | -1,508,000 | -1,618,000 | -1,934,000 | 4,722,000 | -820,000 |
| ROE | 183.05% | 263.89% | 694.44% | 2,181.25% | — | — | — | — | — | — | — | — | — | — | — | 39.31% | — |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $864,000K ÷ $472,000K
= 183.05%
Organon & Co's return on equity (ROE) has shown considerable fluctuations over the reporting periods provided. The ROE was not available for December 2020, and remained undisclosed for the subsequent quarters until March 2021, when it was reported at 39.31%. Subsequently, the ROE experienced a significant increase to 2,181.25% in March 2024, reflecting a substantial improvement in profitability relative to shareholder equity. The ROE then decreased to 694.44% in June 2024, followed by a further decline to 263.89% in September 2024, and eventually settling at 183.05% by December 2024.
These fluctuations in ROE may indicate changes in the company's profitability and efficiency in generating returns for its shareholders. The sharp increase in ROE from 2021 to 2024 suggests a notable improvement in the company's ability to generate profits relative to its equity base. However, the subsequent decreases in ROE could point to potential changes in the company's financial performance, risk profile, or capital structure during the latter part of the reporting period.
It is essential for stakeholders to further analyze the underlying factors driving these fluctuations in ROE to gain a more comprehensive understanding of Organon & Co's financial performance and sustainability over time.
Peer comparison
Dec 31, 2024